Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Concentric Medical enrolls patients in TREVO 2 clinical trial

Concentric Medical has enrolled first patients in TREVO 2 (Thrombectomy REvascularization of large Vessel Occlusions) at Oregon Health & Science University in Portland, Oregon and at Capital Health in Trenton, New Jersey.

TREVO 2 is a pivotal clinical trial investigating the safety and efficacy of Concentric’s Trevo Retriever for removing clot from ischemic stroke patients.

The Trevo Retriever utilizes Stentriever technology, a novel method for retrieving clot from the neurovasculature and is designed for quick access, rapid clot integration and predictable clot retrieval in ischemic stroke patients.

The TREVO 2 study will build upon Concentric’s previous clot retrieval trials, MERCI and Multi MERCI, which have provided compelling evidence of the benefits of retrieving stroke-causing clots from the blood vessels of acute ischemic stroke patients.